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Introduction: Tumor hypoxia results from the negative balance between the oxygen demands of the tissue and the capacity of the 
vasculature to deliver satisfactory oxygen provisions. The resulting oxygen deficit has important consequences in the aggressiveness and 
malignancy of the tumors as well as on their resistance to therapy, endowing the imaging of hypoxia with vital repercussions in tumor 
prognosis and therapy design (1). 2-Nitroimidazole derivatives (EF5, Pimonidzole, 18F-MISO) have been extensively used as molecular 
markers of hypoxia in combination with different techniques as immunohistochemistry, PET or 19F-MRI (2). Their use is based on the in 
vivo reduction of the nitro-group and the subsequent trapping of reactive imidazolyl derivatives in regions of low oxygen tension (3). A key 
issue to be solved in order to fully understand the activity of these markers is to establish precisely the kinetic mechanism for their 
reduction, an aspect that has remained elusive through the years. Here we report on the kinetics of in vitro reduction of commercially 
available, as well as newly synthesized nitroimidazole based hypoxia probes. 
Materials and Methods: We used purified NADPH:cytochrome P450 reductase to investigate in vitro the reduction of four different 2-2-
nitroimidazole derivatives: Pimonidazole, a Misonidazole analog, NIMAC and NISUCA, two novel hypoxia-sensitive probes synthesized 
by us. Phosphate buffered (75 mM, pH= 7.7, 37 ºC, 10% D2O) reaction mixtures containing the probes, NADPH and reduced glutathione 
(GSH, where appropriate), were prepared in 5 mm NMR tubes using TSP (1 mM) as an internal reference. Anoxic conditions were induced 
by sealing the NMR tube with a rubber septum and bubbling pure nitrogen for 30 minutes. For normoxic conditions, tubes were left open 
to the ambient environment during NMR acquisition. The reaction was triggered by the addition of NAPDH:P-450 reductase and the tube 
quickly placed in a Bruker Avance 11.7 Tesla magnet for high resolution 1H NMR acquisitions (π/2 pulse, 32K data table, 6s total cycle 
time, 128 acquisitions) during the following twelve hours. The spectra obtained were analyzed using MestReNova software.  
 
 
 
 
Results: The disappearance of the hypoxia markers and GSH 
resonances, as well as the appearance of corresponding NADP+ and 
GSSG appeared to follow in all cases first order kinetics (Fig 1) 
with an apparent rate constant k´ (Fig 2). Notably, the oxygen 
content in the solution was found not to have a significant effect in 
the reduction rate of these compounds, as indicated by the rate 
constants under normoxia and hypoxia depicted in Fig 2. However, 
the presence of reduced glutathione increased spectacularly the 
reduction rate of all compounds, from 5 to 100 times, far exceeding 
the impact of the changes in oxygen content. When GSH was 
present in the reduction mixture, a plethora of new resonances 
appeared downfield of the resonances from the parental compounds 
(Fig 3). These newly generated signals do not belong to any of the 
known compounds present in the reduction mixture, representing 
clearly, intermediates generated during the reduction reaction.  
Conclusions: It has been previously thought that the main factor 
determining the reduction rate of nitroimidazolyl derivatives in 
tumors was the local oxygen tension. We previously showed that it 
is the intracellular redox state, rather than the oxygen tension, what 
determines the reduction rate of these compounds. In this study, we 
demonstrate that this behavior is common to both commercial and 
newly synthesized 2-nitroimidazolyl derivatives. Since the GSH 
dependent increases in reduction rate occur in all compounds 
investigated, present findings suggest that GSH dependence is a 
general mechanism for nitroimidazolyl reduction in hypoxic zones. 
We report also the appearance of new reaction intermediates 
providing further insight into the mechanism of reduction of these 
hypoxia markers. 
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Fig 2. First order rate constants (k’) for the reduction of 
Misonidazole analog (blue), Pimonidazole (red) and NIMAC 
(green) and NISUCA (purple) under different conditions. 
Fig 3. Regions of the 1H NMR spectra of the reaction mixture at various 
times showing the evolution of the different compounds during the 
reduction of NIMAC with NADPH:cytochrome P450 reductase under 
aerobic conditions in presence of GSH. NIMAC (red), NADPH (green) 
and newly generated signals (blue squares). 
Fig 1. Monoexponential decays of MISO, NADPH and GSH 
resonances and monoexponential increases of NADP+ and GSSG 
resonances after addition of NADPH:Cytochrome P450 reductase. 
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